- Home
- VOR vs PESI Comparison
VOR vs PESI Comparison
Compare VOR & PESI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VOR | PESI |
|---|---|---|
| Founded | 2015 | 1990 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Environmental Services |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 207.1M | 231.8M |
| IPO Year | 2021 | 1992 |
Fundamental Metrics
Financial Performance| Metric | VOR | PESI |
|---|---|---|
| Price | $8.13 | $13.90 |
| Analyst Decision | Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $70.43 | N/A |
| AVG Volume (30 Days) | ★ 1.1M | 175.0K |
| Earning Date | 11-13-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $60,661,000.00 |
| Revenue This Year | N/A | $8.35 |
| Revenue Next Year | N/A | $82.81 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.62 | $6.25 |
| 52 Week High | $65.80 | $16.50 |
Technical Indicators
Market Signals| Indicator | VOR | PESI |
|---|---|---|
| Relative Strength Index (RSI) | 29.79 | 61.34 |
| Support Level | $7.21 | $12.02 |
| Resistance Level | $8.60 | $12.75 |
| Average True Range (ATR) | 0.87 | 0.65 |
| MACD | 0.55 | 0.15 |
| Stochastic Oscillator | 44.80 | 91.28 |
Price Performance
Historical ComparisonAbout VOR Vor Biopharma Inc.
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.
About PESI Perma-Fix Environmental Services Inc.
Perma-Fix Environmental Services Inc is a provider of both nuclear services and the management of nuclear and mixed waste. The company operates through two segments: The treatment segment offers nuclear, low-level radioactive, Mixed, hazardous and non-hazardous waste treatment, processing and disposal services, and the Services segment which generates the majority of the revenue, provides on-site waste management services to commercial and government customers, technology-based services, construction, logistics, and transportation services among others.